Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma

AIM: To study the activity of gemcitabine and cisplatin in a cohort of patients with inoperable or metastatic cholangiocarcinoma. METHODS: Chemotherapy-naive patients with pathologically proven cholangiocarcinoma, receiving treatment that consisted of gemcitabine at 1250 mg/m(2) in a 30-min infusion...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:World J Gastroenterol
Prif Awduron: Charoentum, Chaiyut, Thongprasert, Sumitra, Chewaskulyong, Busyamas, Munprakan, Sutthirak
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Co., Limited 2007
Pynciau:
Rapid Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4395638/
https://ncbi.nlm.nih.gov/pubmed/17569122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i20.2852
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg